Jardiance sparks Boehringer Ingelheim’s 2021 growth, with more likely on the waynews2022-04-05T13:21:56+00:00April 5th, 2022|Fierce Pharma|
How did Merck record an 11% tax rate last year? The Senate finance chairman would like to knownews2022-04-05T13:19:07+00:00April 5th, 2022|Fierce Pharma|
Bluebird bio cuts 30% of its workforce as gene therapy dreams dashed in Europe, delayed in USnews2022-04-05T13:03:27+00:00April 5th, 2022|Fierce Pharma|
Novartis gets FDA nod to begin making Zolgensma in North Carolinanews2022-04-05T12:51:01+00:00April 5th, 2022|Fierce Pharma|
Genprex pairs gene therapy delivery tech with Keytruda in lung cancer trialnews2022-04-05T12:45:21+00:00April 5th, 2022|Fierce Pharma|
Physician poll finds ultralong-acting regimens and home administration could transform HIV marketnews2022-04-05T10:38:24+00:00April 5th, 2022|Fierce Pharma|
Oral prolonged-release ketamine advances after COVID-disrupted trialnews2022-04-05T10:33:59+00:00April 5th, 2022|Fierce Pharma|
In a first, FDA approves topical sirolimus for rare disease lesionsnews2022-04-05T10:28:33+00:00April 5th, 2022|Fierce Pharma|
Ukraine war, China’s COVID lockdown and more could weigh on J&J’s early-year performance—and it may not be alone: analystsnews2022-04-04T18:27:54+00:00April 4th, 2022|Fierce Pharma|
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patientsnews2022-04-04T16:53:49+00:00April 4th, 2022|Fierce Pharma|
